Géraldine Descamps

1.5k total citations
30 papers, 1.1k citations indexed

About

Géraldine Descamps is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Géraldine Descamps has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Hematology and 9 papers in Oncology. Recurrent topics in Géraldine Descamps's work include Multiple Myeloma Research and Treatments (17 papers), Ubiquitin and proteasome pathways (11 papers) and Protein Degradation and Inhibitors (6 papers). Géraldine Descamps is often cited by papers focused on Multiple Myeloma Research and Treatments (17 papers), Ubiquitin and proteasome pathways (11 papers) and Protein Degradation and Inhibitors (6 papers). Géraldine Descamps collaborates with scholars based in France, Switzerland and Germany. Géraldine Descamps's co-authors include Catherine Pellat‐Deceunynck, Martine Amiot, Régis Bataille, Philippe Moreau, Sophie Maïga, Steven Le Gouill, Patricia Gomez‐Bougie, Gaëtan Jégo, Benoît Tessoulin and David Chiron and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Géraldine Descamps

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Géraldine Descamps France 20 731 429 350 253 116 30 1.1k
Michele S. Redell United States 18 562 0.8× 315 0.7× 402 1.1× 203 0.8× 100 0.9× 50 1.1k
Patricia Gomez‐Bougie France 22 1.0k 1.4× 463 1.1× 395 1.1× 201 0.8× 182 1.6× 38 1.3k
Bangzheng Chen United States 6 584 0.8× 430 1.0× 320 0.9× 155 0.6× 114 1.0× 8 900
Monica Pallis United Kingdom 23 674 0.9× 590 1.4× 509 1.5× 155 0.6× 63 0.5× 61 1.3k
S P Treon United States 13 540 0.7× 457 1.1× 447 1.3× 151 0.6× 151 1.3× 20 958
Binje Vick Germany 16 540 0.7× 248 0.6× 471 1.3× 314 1.2× 65 0.6× 32 1.1k
Simona Blotta United States 12 663 0.9× 298 0.7× 452 1.3× 189 0.7× 71 0.6× 22 1.0k
Masato Shikami Japan 18 703 1.0× 451 1.1× 381 1.1× 180 0.7× 73 0.6× 31 1.1k
Iris Breitkreutz United States 14 879 1.2× 1.0k 2.4× 697 2.0× 204 0.8× 130 1.1× 34 1.5k
Elisabetta Calabrese Italy 13 508 0.7× 356 0.8× 399 1.1× 185 0.7× 131 1.1× 37 1.0k

Countries citing papers authored by Géraldine Descamps

Since Specialization
Citations

This map shows the geographic impact of Géraldine Descamps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Géraldine Descamps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Géraldine Descamps more than expected).

Fields of papers citing papers by Géraldine Descamps

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Géraldine Descamps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Géraldine Descamps. The network helps show where Géraldine Descamps may publish in the future.

Co-authorship network of co-authors of Géraldine Descamps

This figure shows the co-authorship network connecting the top 25 collaborators of Géraldine Descamps. A scholar is included among the top collaborators of Géraldine Descamps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Géraldine Descamps. Géraldine Descamps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maïga, Sophie, Christelle Dousset, Agnès Moreau‐Aubry, et al.. (2025). VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target. Leukemia. 39(4). 995–1000.
2.
Descamps, Géraldine, Céline Bellanger, Christelle Dousset, et al.. (2023). A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics. Blood. 143(13). 1242–1258. 7 indexed citations
3.
Maïga, Sophie, Cyrille Touzeau, Céline Bellanger, et al.. (2020). Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes. Cell Death and Disease. 11(5). 316–316. 34 indexed citations
4.
Tessoulin, Benoît, Géraldine Descamps, Christelle Dousset, Martine Amiot, & Catherine Pellat‐Deceunynck. (2019). Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells. Frontiers in Oncology. 9. 128–128. 24 indexed citations
5.
Tessoulin, Benoît, Agnès Moreau‐Aubry, Géraldine Descamps, et al.. (2018). Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways. Journal of Hematology & Oncology. 11(1). 137–137. 35 indexed citations
6.
Descamps, Géraldine, Sophie Maïga, Benoît Tessoulin, et al.. (2017). Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells. International Journal of Molecular Sciences. 19(1). 40–40. 3 indexed citations
7.
Lok, Anne, Géraldine Descamps, Benoît Tessoulin, et al.. (2016). The Oncolytic Measles Virus Preferentially Infects p53 Abnormal Myeloma Cells. Blood. 128(22). 310–310. 1 indexed citations
8.
Surget, Sylvanie, Géraldine Descamps, Carole Brosseau, et al.. (2014). RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53 abnormal myeloma cells independently of the p53 pathway. BMC Cancer. 14(1). 437–437. 19 indexed citations
9.
Chiron, David, Sophie Maïga, Sylvanie Surget, et al.. (2013). Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells. Blood Cancer Journal. 3(6). e120–e120. 24 indexed citations
10.
Surget, Sylvanie, David Chiron, Patricia Gomez‐Bougie, et al.. (2012). Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells. Cancer Research. 72(17). 4562–4573. 58 indexed citations
11.
Chiron, David, Sophie Maïga, Géraldine Descamps, et al.. (2012). Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells. Blood Cells Molecules and Diseases. 48(4). 247–253. 22 indexed citations
12.
Descamps, Géraldine, Patricia Gomez‐Bougie, Jérôme Tamburini, et al.. (2012). The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction. British Journal of Cancer. 106(10). 1660–1667. 46 indexed citations
13.
Chiron, David, et al.. (2011). TLR9 Ligand Induces the Generation of CD20+ Plasmablasts and Plasma Cells from CD27+ Memory B-Cells. SHILAP Revista de lepidopterología. 2. 83–83. 22 indexed citations
14.
Moreaux, Jérôme, Bernard Klein, Régis Bataille, et al.. (2010). A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines. Haematologica. 96(4). 574–582. 124 indexed citations
15.
Ménoret, Emmanuelle, Sophie Maïga, Géraldine Descamps, et al.. (2008). IL-21 Stimulates Human Myeloma Cell Growth through an Autocrine IGF-1 Loop. The Journal of Immunology. 181(10). 6837–6842. 30 indexed citations
16.
Kihel, Laïla El, et al.. (2008). New lithocholic and chenodeoxycholic piperazinylcarboxamides with antiproliferative and pro-apoptotic effects on human cancer cell lines. Bioorganic & Medicinal Chemistry. 16(18). 8737–8744. 31 indexed citations
17.
Descamps, Géraldine, Soraya Wuillème‐Toumi, Valérie Trichet, et al.. (2006). CD45neg but Not CD45pos Human Myeloma Cells Are Sensitive to the Inhibition of IGF-1 Signaling by a Murine Anti-IGF-1R Monoclonal Antibody, mAVE1642. The Journal of Immunology. 177(6). 4218–4223. 32 indexed citations
18.
Jégo, Gaëtan, et al.. (2006). Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors. Leukemia. 20(6). 1130–1137. 134 indexed citations
19.
Descamps, Géraldine, et al.. (2004). The Magnitude of Akt/Phosphatidylinositol 3′-Kinase Proliferating Signaling Is Related to CD45 Expression in Human Myeloma Cells. The Journal of Immunology. 173(8). 4953–4959. 34 indexed citations
20.
Amessou, Mohamed, et al.. (1998). Increased expression of liver PKC α in hypoinsulinemic diabetic rats: a post-translational effect. Molecular and Cellular Endocrinology. 146(1-2). 177–185. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michele S. Redell Breakdown of academic impact, for papers by Patricia Gomez‐Bougie Breakdown of academic impact, for papers by Bangzheng Chen Breakdown of academic impact, for papers by Monica Pallis Breakdown of academic impact, for papers by S P Treon Breakdown of academic impact, for papers by Binje Vick Breakdown of academic impact, for papers by Simona Blotta Breakdown of academic impact, for papers by Masato Shikami Breakdown of academic impact, for papers by Iris Breitkreutz Breakdown of academic impact, for papers by Elisabetta Calabrese
Rankless by CCL
2026